跳至主要内容
临床试验/NCT04242667
NCT04242667已完成不适用

A Randomized Protocol Evaluating Return of Actionable Genetic Research Results to Biobank Participants

Abramson Cancer Center at Penn Medicine2 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
260
试验地点
2
主要终点
Completion of surveys

研究概览

简要总结

The overall goal of the proposed research is to assess the feasibility of a randomized study evaluating the non-inferiority of an electronic Health (e-Health) delivery alternative (e.g. private web portal) as compared to return of actionable genetic research results with a genetic counselor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consented participant in University of Pennsylvania Biobank who previously submitted a DNA sample for research testing
  • English speaking
  • Aged 18 years or older
  • Agreed to be re-contacted in the future or did not indicate a preference on future contact regarding research results
  • Have an actionable mutation or have been selected as a control participant
  • Have not previously received actionable results of clinical genetic testing

排除标准

  • Deceased assessed by electronic medical record, death index or identified after contact
  • Evidence in the electronic medical record that the subject has already received the same actionable result through clinical genetic testing

结局指标

主要结局

Completion of surveys

时间窗: Baseline survey prior to disclosure of results, and then two post-disclosure surveys at 2-7 days and 6 months

Participant will self-complete surveys to collect psychological and knowledge outcomes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验